Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-29

Clinical Trial Update: Promoting Stress Management and Resilience Among Individuals With Von Hippel- Lindau Disease [NA]

View source ↗

Summary

A clinical trial update indicates that Massachusetts General Hospital is enrolling by invitation to study stress management and resilience in individuals with V…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Von Hippel-Lindau Disease, Genetic Disorder | NA | Status: ENROLLING_BY_INVITATION